These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27537361)

  • 1. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.
    Zitt E; Pscheidt C; Concin H; Kramar R; Lhotta K; Nagel G
    PLoS One; 2016; 11(8):e0161376. PubMed ID: 27537361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.
    Pscheidt C; Nagel G; Zitt E; Kramar R; Concin H; Lhotta K
    PLoS One; 2015; 10(8):e0135052. PubMed ID: 26322515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality.
    Ulmer H; Kelleher C; Diem G; Concin H
    J Womens Health (Larchmt); 2004; 13(1):41-53. PubMed ID: 15006277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-related end-stage renal disease in Austria 1965-2013.
    Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
    Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
    Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
    Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study.
    Shen ZW; Xing J; Wang QL; Faheem A; Ji X; Li J; Bian WW; Jiang Z; Li XJ; Xue FZ; Liu J
    Int Urol Nephrol; 2017 Feb; 49(2):303-312. PubMed ID: 27704320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
    O'Shaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Eur Heart J; 2019 Mar; 40(11):887-898. PubMed ID: 30085056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
    Jankowska M; Qureshi AR; Barany P; Heimburger O; Stenvinkel P; Lindholm B
    Nephrology (Carlton); 2018 Jan; 23(1):31-36. PubMed ID: 27653449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland.
    Kastarinen M; Juutilainen A; Kastarinen H; Salomaa V; Karhapää P; Tuomilehto J; Grönhagen-Riska C; Jousilahti P; Finne P
    J Intern Med; 2010 Jun; 267(6):612-20. PubMed ID: 20210838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure, body mass index, heart rate and levels of blood cholesterol and glucose of volunteers during National Heart Weeks, 1995-1997.
    Khoo KL; Tan H; Liew YM; Sambhi JS; Aljafri AM; Hatijah A
    Med J Malaysia; 2000 Dec; 55(4):439-50. PubMed ID: 11221155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study.
    Lee DY; Han K; Yu JH; Park S; Heo JI; Seo JA; Kim NH; Yoo HJ; Kim SG; Kim SM; Choi KM; Baik SH; Park YG; Kim NH
    Sci Rep; 2020 Jul; 10(1):11668. PubMed ID: 32669624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral.
    Crook ED; Harris J; Oliver B; Fleischman E; Crenshaw G; Taylor R
    J Investig Med; 2001 May; 49(3):284-91. PubMed ID: 11352187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults.
    Fritz J; Brozek W; Concin H; Nagel G; Kerschbaum J; Lhotta K; Ulmer H; Zitt E
    JAMA Netw Open; 2021 Mar; 4(3):e212612. PubMed ID: 33787913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
    Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
    Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.
    Rapp K; Schroeder J; Klenk J; Ulmer H; Concin H; Diem G; Oberaigner W; Weiland SK
    Diabetologia; 2006 May; 49(5):945-52. PubMed ID: 16557372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index in 1.2 million adolescents and risk for end-stage renal disease.
    Vivante A; Golan E; Tzur D; Leiba A; Tirosh A; Skorecki K; Calderon-Margalit R
    Arch Intern Med; 2012 Nov; 172(21):1644-50. PubMed ID: 23108588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.